e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
This study is testing a new web-based program called ePSMI to help pancreatic cancer patients manage stress and symptoms. The ePSMI program involves weekly one-hour sessions of cognitive behavioral stress management, which can be done in person or remotely for ten weeks. This program aims to reduce anxiety and help change negative thoughts. You may be able to join if you are over 18, speak English or Spanish, and have been diagnosed with pancreatic cancer or pancreatic neuroendocrine tumor (PNET). The researchers will measure how many people join, stay in the study, and participate in the program over one year to see how well it works.
- Study design
- This interventional study plans to enroll 60 participants. It is designed to evaluate a behavioral intervention.
- What's involved
- Participants will complete an hour of cognitive behavioral stress management program each week for ten weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to one year to measure recruitment, retention, and participation.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Frank Penedo, PhD · PRINCIPAL_INVESTIGATOR · University of Miami
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Percentage of Participants RecruitedUp to 1 year.
Will be measured in percentages (%). The study will be considered feasible passed 60%.
- Percentage of Participants RetainedUp to 1 year.
Will be measured in percentages (%). The study will be considered feasible passed ≥ 80%.
- Percentage of Study ParticipationUp to 1 year.
Will be measured in percentages (%). The study will be considered feasible passed ≥ 80%.
- Number of CallsUp to 10 weeks.
It will be measured by number of biweekly calls.
- Theoretical Framework on Acceptability QuestionnaireUp to 10 weeks.
Scores will range from 10-50. Higher scores indicate higher acceptability.
- Functional Assessment of Cancer Therapy (FACT) - Functional Hepatobiliary-Pancreatic Symptom Index (FHSI)-18Up to 10 weeks.
Scores will range 0-72 with lower scores indicating better quality of life.
- Patient-Reported Outcomes Measurement Information System - Pain Short FormUp to 10 weeks.
Scores will range 0-80 with higher scores indicating higher pain symptoms
- Patient-Reported Outcomes Measurement Information System - Fatigue Short FormUp to 10 weeks.
Scores will range 0-80 with higher scores indicating higher fatigue symptoms
- Pittsburgh Sleep Quality Index (PSQI)Up to 10 weeks.
Scores will range from 0-21 with higher scores indicating worse sleep quality.
- Gastrointestinal Symptom Rating Scale (GSRS)Up to 10 weeks.
Scores will range from 0-78 with higher scores indicating worse gastrointestinal symptoms.